contents area
난치성질환
- Date2019-05-15
- Update2021-12-27
detail content area
목적
- 난치성질환 극복을 위한 줄기세포 연구 및 재생의료 실용화 지원
업무분야
국가줄기세포은행
- 연구용 및 임상용 줄기세포 자원 확보, 배양, 품질관리, 보관 및 분양
- 줄기세포 품질관리를 위한 연구 및 표준화를 위한 국제협력
- 줄기세포 활용 질병 모델링 및 치료제 개발 연구
- 인간 배아줄기세포주 등록
GMP 제조시설
- 임상연구용 세포치료제 제조 지원
- 3차원 바이오프린팅 조직공학치료제 등 차세대 재생의료 치료제 제조기반 구축
- GMP 전문인력 양성
>>> 국가줄기세포은행 분양 줄기세포 목록
>>> GMP 제조시설 현황 및 이용신청절차
추진경과
일 자 | 주요 내용 |
---|---|
2008.6 | 「생명윤리 및 안전에 관한 법률」개정 |
2010.1 | 「생명윤리 및 안전에 관한 법률」에 따른 인간배아줄기세포주 등록 사업 개시 |
2012.7 | 국립줄기세포재생센터 건립 기본계획 수립 |
2012.10 | 질병관리본부내 국가줄기세포은행 개소 |
2014.3 | 국립줄기세포재생센터 착공식 |
2014.10 | 국가줄기세포은행 자원분양 개시 |
2016.10 | 국립줄기세포재생센터 개소식 |
2017.5 | 국가줄기세포은행 기탁등록보존기관 지정 |
2017.12 | 국립줄기세포재생센터 제조시설 검증 완료 |
2018.6 | 임상연구용 세포치료제 시범생산 성공 |
2018.8 | 임상연구용 세포치료제 제조지원 품목 선정 |
2018.10 | 임상연구용 세포치료제 제조지원 개시 |
논문목록(2017~)
- Lee YS et al. Establishment of a human-induced pluripotent stem cell line, KSCBi014-A, from a long QT syndrome type 2 patient harboring a KCNH2 mutation. Stem Cell Res. 2021.
- Han HJ et al. Generation of a TLR2 knockout human induced pluripotent stem cell line using CRISPR/Cas9. Stem Cell Res. 2021.
- Lee YS et al. Establishment of a human induced pluripotent stem cell line, KSCBi015-A, from a long QT syndrome type 1 patient harboring a KCNQ1 mutation. Stem Cell Res. 2021.
- Kim JH et al. Korea National Stem Cell Bank. Stem Cell Res. 2021.
- Han HJ et al. Establishment of a TLR3 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9. Stem Cell Res. 2021.
- Jo HY et al. Functional in vivo and in vitro effects of 20q11.21 genetic aberrations on hPSC differentiation. Sci Rep. 2020.
- Seo HH et al. Modeling Toxoplasma gondii infection in human cerebral organoids. EMI. 2020.
- Kim BY et al. Generation of induced pluripotent stem cells(KSCBi009-A) from a patient with Prader-Willi syndrome(PWS) featuring deletion of the paternal chromosome region 15q11.2-q13. Stem Cell Res. 2020.
- Seo HH et al. Generation of a TLR7 heterozygous knockout line (WAe009-A-18) from human embryonic stem cells using CRISPR/Cas9. Stem Cell Res. 2020.
- Park HY et al. Generation of a human induced pluripotent stem cell line from a patient with Leber congenital amaurosis. Stem Cell Res. 2020.
- Jo HY et al. Development of genetic quality tests for good manufacturing practice-compliant induced pluripotent stem cells and their derivatives. Sci Rep. 2020.
- Yoo DH et al. Simple differentiation method using FBS identifies DUSP6 as a marker for fine-tuning of FGF-ERK signaling activity in human pluripotent stem cells. BBRC. 2020.
- Park HY et al. Generation of human induced pluripotent stem cells from peripheral blood mononuclear cells of a Senior-Loken syndrome patient. Stem Cell Res. 2019.
- Kim BY et al. Generation of patient-specific induced pluripotent stem cells(KSCBi007-A) derived from a patient with Prader-Willi syndrome retain maternal uniparental disomy(UPD). Stem Cell Res. 2019.
- Lee YS et al. Generation of a PDX1-EFGP reporter human induced pluripotent stem cell line, KSCBi005-A-3, using CRISPR/Cas9 system. Stem Cell Res. 2019.
- Han HW et al. Drug Discovery Platform Targeting M. tuberculosis with Human Embryonic Stem Cell-Derived Macrophages. Stem Cell Rep. 2019.
- Kim BY et al. Generation of a patient-specific induced pluripotent stem cell line, KSCBi006-A, for osteogenesis imperfecta type I with the COL1A1, c.3162delT mutation. Stem Cell Res. 2019.
- Han HJ et al. Generation of a KSCBi005-A-5(TLR8KO-A10) homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9. Stem Cell Res. 2019.
- Lee YS et al. Generation of a NESTIN-EFGP reporter human induced pluripotent stem cell line, KSCBi005-A-1, using CRISPR/Cas9 nuclease. Stem Cell Res. 2019.
- Han HJ et al. Generation of a TLR7 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9. Stem Cell Res. 2019.
- Kim JH et al. A Report from a Workshop of the International Stem Cell Banking Initiative, Held in Collaboration of Global Alliance for iPSC Therapies and the Harvard Stem Cell Institute, Boston, 2017. Stem Cells. 2019.
- Choi HY et al. Generation of a human induced pluripotent stem cell line, KSCBi003-A, from human adipose tissue-derived mesenchymal stem cells using a chromosomal integration-free system. Stem Cell Res. 2018.
- Kim BY et al. Genetic analysis of parathyroid and pancreatic tumors in a patient with multiple endocrine neoplasia type 1 using whole-exome sequencing. BMC Med Genet. 2017.
- Kim JH et al. Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells. Stem Cells Transl Med. 2017.
- Uhm KO et al. Generation of human induced pluripotent stem cell lines from human dermal fibroblasts using a modified RNA system. Stem Cell Res. 2017.
- Kim BY et al. Optimized detection of insertions/deletions (INDELs) in whole-exome sequencing data. PLoS One. 2017.
- Uhm KO et al. Generation of human induced pluripotent stem cells from urinary cells of a healthy donor using a non-integration system. Stem Cell Res. 2017.
- Uhm KO et al. Generation of human induced pluripotent stem cell lines from human dermal fibroblasts using a non-integration system. Stem Cell Res. 2017.